379 related articles for article (PubMed ID: 25295247)
21. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
[TBL] [Abstract][Full Text] [Related]
22. The release of tryptase from mast cells promote tumor cell metastasis via exosomes.
Xiao H; He M; Xie G; Liu Y; Zhao Y; Ye X; Li X; Zhang M
BMC Cancer; 2019 Oct; 19(1):1015. PubMed ID: 31664930
[TBL] [Abstract][Full Text] [Related]
23. VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis.
Ciurea R; Mărgăritescu C; Simionescu C; Stepan A; Ciurea M
Rom J Morphol Embryol; 2011; 52(4):1227-32. PubMed ID: 22203927
[TBL] [Abstract][Full Text] [Related]
24. Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2.
Asano-Kato N; Fukagawa K; Okada N; Dogru M; Tsubota K; Fujishima H
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4622-6. PubMed ID: 16303958
[TBL] [Abstract][Full Text] [Related]
25. CAPE suppresses VEGFR-2 activation, and tumor neovascularization and growth.
Chung TW; Kim SJ; Choi HJ; Kwak CH; Song KH; Suh SJ; Kim KJ; Ha KT; Park YG; Chang YC; Chang HW; Lee YC; Kim CH
J Mol Med (Berl); 2013 Feb; 91(2):271-82. PubMed ID: 22935775
[TBL] [Abstract][Full Text] [Related]
26. Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners.
Yoshii M; Jikuhara A; Mori S; Iwagaki H; Takahashi HK; Nishibori M; Tanaka N
J Pharmacol Sci; 2005 Aug; 98(4):450-8. PubMed ID: 16093613
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Associated Macrophages and Mast Cells Positive to Tryptase Are Correlated with Angiogenesis in Surgically-Treated Gastric Cancer Patients.
Sammarco G; Gadaleta CD; Zuccalà V; Albayrak E; Patruno R; Milella P; Sacco R; Ammendola M; Ranieri G
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649166
[TBL] [Abstract][Full Text] [Related]
28. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms.
Mäyränpää MI; Trosien JA; Fontaine V; Folkesson M; Kazi M; Eriksson P; Swedenborg J; Hedin U
J Vasc Surg; 2009 Aug; 50(2):388-95; discussion 395-6. PubMed ID: 19515525
[TBL] [Abstract][Full Text] [Related]
29. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
30. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
Stevens RL; Adachi R
Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058
[TBL] [Abstract][Full Text] [Related]
31. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.
Wroblewski M; Bauer R; Cubas Córdova M; Udonta F; Ben-Batalla I; Legler K; Hauser C; Egberts J; Janning M; Velthaus J; Schulze C; Pantel K; Bokemeyer C; Loges S
Nat Commun; 2017 Aug; 8(1):269. PubMed ID: 28814715
[TBL] [Abstract][Full Text] [Related]
32. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix.
Benítez-Bribiesca L; Wong A; Utrera D; Castellanos E
J Histochem Cytochem; 2001 Aug; 49(8):1061-2. PubMed ID: 11457936
[TBL] [Abstract][Full Text] [Related]
33. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium.
Ribatti D; Nico B; Maxia C; Longo V; Murtas D; Mangieri D; Perra MT; De Giorgis M; Piras F; Crivellato E; Sirigu P
J Cell Mol Med; 2007; 11(3):585-9. PubMed ID: 17635650
[TBL] [Abstract][Full Text] [Related]
34. Mast cells, angiogenesis, and tumour growth.
Ribatti D; Crivellato E
Biochim Biophys Acta; 2012 Jan; 1822(1):2-8. PubMed ID: 21130163
[TBL] [Abstract][Full Text] [Related]
35. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium.
Meyer MC; Creer MH; McHowat J
Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1485-91. PubMed ID: 16079184
[TBL] [Abstract][Full Text] [Related]
36. Human mast cells arise from a common circulating progenitor.
Maaninka K; Lappalainen J; Kovanen PT
J Allergy Clin Immunol; 2013 Aug; 132(2):463-9.e3. PubMed ID: 23582567
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
[TBL] [Abstract][Full Text] [Related]
38. Mast cell tryptase beta as a target in allergic inflammation: an evolving story.
Sommerhoff CP; Schaschke N
Curr Pharm Des; 2007; 13(3):313-32. PubMed ID: 17313363
[TBL] [Abstract][Full Text] [Related]
39. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes.
Vliagoftis H; Lacy P; Luy B; Adamko D; Hollenberg M; Befus D; Moqbel R
Int Arch Allergy Immunol; 2004 Nov; 135(3):196-204. PubMed ID: 15467372
[TBL] [Abstract][Full Text] [Related]
40. Induction of Mast Cell Accumulation by Tryptase via a Protease Activated Receptor-2 and ICAM-1 Dependent Mechanism.
Liu X; Wang J; Zhang H; Zhan M; Chen H; Fang Z; Xu C; Chen H; He S
Mediators Inflamm; 2016; 2016():6431574. PubMed ID: 27378825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
